메뉴 건너뛰기




Volumn 56, Issue 2 A, 2006, Pages 136-151

Large-scale synthesis and formulation of GMP-grade stampidine, a new anti-HIV agent

Author keywords

Anti HIV agents; Antiretroviral therapy; CAS 217178 62 6; CAS 3056 17 5; DDE 113; HI 113; N p (4 bromophenyl) 2',3' didehydro 3' deoxy 5' thymidylyl L alanine methyl ester; Stampidine, formulation, GMP, synthesis; Stavudine

Indexed keywords

CAS 217178 62 6; CAS 3056 17 5; DDE 113; HI 113; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAMPIDINE; STAVUDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

EID: 33645101334     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296801     Document Type: Article
Times cited : (9)

References (17)
  • 1
    • 33645108943 scopus 로고    scopus 로고
    • USA Patent No. 6,503,890. Issued: 1/7/2003. Aryl phosphate derivatives of d4T having anti-HIV activity
    • USA Patent No. 6,503,890. Issued: 1/7/2003. Aryl phosphate derivatives of d4T having anti-HIV activity. Uckun, F. M., Vig, R.
    • Uckun, F.M.1    Vig, R.2
  • 2
    • 33645109345 scopus 로고    scopus 로고
    • Patent No. EP 1 090 018 B1. Issued: 9/29/2004. Aryl phosphate derivatives of d4T having anti-HIV activity
    • Patent No. EP 1 090 018 B1. Issued: 9/29/2004. Aryl phosphate derivatives of d4T having anti-HIV activity. Uckun, F. M., Vig, R.
    • Uckun, F.M.1    Vig, R.2
  • 3
    • 33645096581 scopus 로고    scopus 로고
    • Patent Application No. WO 00/000501. Issued: 1/6/00 Aryl phosphate derivatives of d4T having anti-HIV activity
    • Patent Application No. WO 00/000501. Issued: 1/6/00 Aryl phosphate derivatives of d4T having anti-HIV activity. Uckun, F. M., Vig, R.
    • Uckun, F.M.1    Vig, R.2
  • 4
    • 33645097090 scopus 로고    scopus 로고
    • USA Patent No. 6,350,736. Issued: 2/26/2002. Aryl phosphate derivatives of d4T having anti-HIV activity
    • USA Patent No. 6,350,736. Issued: 2/26/2002. Aryl phosphate derivatives of d4T having anti-HIV activity. Uckun, F. M., Vig, R.
    • Uckun, F.M.1    Vig, R.2
  • 5
    • 33645097851 scopus 로고    scopus 로고
    • USA Patent No. 6,030,957. Issued: 2/29/2000. Aryl phosphate derivatives of d4T having anti-HIV activity
    • USA Patent No. 6,030,957. Issued: 2/29/2000. Aryl phosphate derivatives of d4T having anti-HIV activity. Uckun, F. M., Vig, R.
    • Uckun, F.M.1    Vig, R.2
  • 6
    • 33645102816 scopus 로고    scopus 로고
    • USA Patent No. 6,825,177. Issued: 11/30/2004. Aryl phosphate derivatives of d4T with potent anti-viral activity
    • USA Patent No. 6,825,177. Issued: 11/30/2004. Aryl phosphate derivatives of d4T with potent anti-viral activity. Uckun, F. M., Chen, C.-L., Venkatachalam, T. K., et al.
    • Uckun, F.M.1    Chen, C.-L.2    Venkatachalam, T.K.3
  • 7
    • 33645109499 scopus 로고    scopus 로고
    • USA Patent Application No. 20040077607. Issued: 4/22/ 2004. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
    • USA Patent Application No. 20040077607. Issued: 4/22/ 2004. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses. Uckun, F. M.
    • Uckun, F.M.1
  • 8
    • 33645103046 scopus 로고    scopus 로고
    • USA Patent Application No. 20040087549. Issued: 5/6/ 2004. Aryl phosphate derivatives of d4T having activity against resistant HIV strains
    • USA Patent Application No. 20040087549. Issued: 5/6/ 2004. Aryl phosphate derivatives of d4T having activity against resistant HIV strains. Uckun, F. M.
    • Uckun, F.M.1
  • 9
    • 33645100943 scopus 로고    scopus 로고
    • USA Patent Application No. 20030236218. Issued: 12/25/ 2003. Aryl phosphate derivatives of d4T with selective activity against adenovirus and HIV
    • USA Patent Application No. 20030236218. Issued: 12/25/ 2003. Aryl phosphate derivatives of d4T with selective activity against adenovirus and HIV Uckun, F. M.
    • Uckun, F.M.1
  • 10
    • 17644412826 scopus 로고    scopus 로고
    • In vitro anti-HIV potency of STAMP alone and in combination with standard anti-HIV drugs
    • Uckun, F. M., Qazi, S., Venkatachalam, T. K., In vitro anti-HIV potency of STAMP alone and in combination with standard anti-HIV drugs. Arzneim.-Forsch./Drug Res. 55, 223 (2005)
    • (2005) Arzneim.-Forsch./Drug Res. , vol.55 , pp. 223
    • Uckun, F.M.1    Qazi, S.2    Venkatachalam, T.K.3
  • 11
    • 0036841755 scopus 로고    scopus 로고
    • In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of STV-5'-(p-bromophenyl methoxyalaninyl phosphate) (STAMP) in mice
    • Uckun, F. M., Qazi, S., Pendergrass, S. et al., In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of STV-5'-(p-bromophenyl methoxyalaninyl phosphate) (STAMP) in mice. Antimicrob. Agents Chemother. 46, 3428 (2002)
    • (2002) Antimicrob. Agents Chemother. , vol.46 , pp. 3428
    • Uckun, F.M.1    Qazi, S.2    Pendergrass, S.3
  • 12
    • 0036840520 scopus 로고    scopus 로고
    • Stampidine is a potent inhibitor of zidovudine- and nucleoside analog reverse-transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations
    • Uckun, F. M., Pendergrass, S., Venkatachalam, T. K. et al., Stampidine is a potent inhibitor of zidovudine- and nucleoside analog reverse-transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations. Antimicrob. Agents Chemother. 46, 3613 (2002)
    • (2002) Antimicrob. Agents Chemother. , vol.46 , pp. 3613
    • Uckun, F.M.1    Pendergrass, S.2    Venkatachalam, T.K.3
  • 13
    • 0742322029 scopus 로고    scopus 로고
    • In vitro activity of STAMP against primary clinical human immunodeficiency virus isolates
    • Uckun, F. M., Pendergrass, S., Qazi, S. et al., In vitro activity of STAMP against primary clinical human immunodeficiency virus isolates. Arzneim.-Forsch./Drug Res.. 54, 69 (2004)
    • (2004) Arzneim.-Forsch./Drug Res.. , vol.54 , pp. 69
    • Uckun, F.M.1    Pendergrass, S.2    Qazi, S.3
  • 14
    • 0037378795 scopus 로고    scopus 로고
    • In vivo antiretroviral activity of STAMP in chronically feline immunodeficiency virus-infected cats
    • Uckun, F. M., Chen, C. L., Samuel, P. et al., In vivo antiretroviral activity of STAMP in chronically feline immunodeficiency virus-infected cats. Antimicrob. Agents Chemother. 47, 1233 (2003)
    • (2003) Antimicrob. Agents Chemother. , vol.47 , pp. 1233
    • Uckun, F.M.1    Chen, C.L.2    Samuel, P.3
  • 15
    • 0038627530 scopus 로고    scopus 로고
    • Toxicity and pharmacokinetics of STAMP in mice and rats
    • Uckun, F. M., Chen, C. L., Lisowski, E. et al., Toxicity and pharmacokinetics of STAMP in mice and rats. Arzneim.-Forsch./Drug Res. 53, 357 (2003)
    • (2003) Arzneim.-Forsch./Drug Res. , vol.53 , pp. 357
    • Uckun, F.M.1    Chen, C.L.2    Lisowski, E.3
  • 16
    • 0034962198 scopus 로고    scopus 로고
    • In vivo pharmacokinetics and metabolism of anti-human immunodeficiency virus agent D4T-5'-[p-bromophenyl methoxyalaninyl phosphate] (STAMP) in mice
    • Chen, C. L., Venkatachalam, T. K., Zhu, Z. H. et al., In vivo pharmacokinetics and metabolism of anti-human immunodeficiency virus agent D4T-5'-[p-bromophenyl methoxyalaninyl phosphate] (STAMP) in mice. Drug Metab. Dispos. 29, 1035 (2001)
    • (2001) Drug Metab. Dispos. , vol.29 , pp. 1035
    • Chen, C.L.1    Venkatachalam, T.K.2    Zhu, Z.H.3
  • 17
    • 1842833698 scopus 로고    scopus 로고
    • Metabolism of STV-5'-[p-bromophenyl methoxyalaninyl phosphate], STAMP, in mice, dogs, and cats
    • Chen, C. L., Yu, G., Venkatachalam, T. K. et al., Metabolism of STV-5'-[p-bromophenyl methoxyalaninyl phosphate], STAMP, in mice, dogs, and cats. Drug Metab. Dispos. 30, 1523 (2002)
    • (2002) Drug Metab. Dispos. , vol.30 , pp. 1523
    • Chen, C.L.1    Yu, G.2    Venkatachalam, T.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.